New Research Highlights SOMAVEDIC's Potential
in Enhancing Vision Health for the Opthalmology Unit Hospital
Patients
SAN
FRANCISCO, April 23, 2024 /PRNewswire/ -- Somavedic,
a trailblazer in sleep and digital pollution-neutralizing frequency
therapy technology, in collaboration with researchers from the Eye
Clinic of Jan Evangelista Purkyně University and Masaryk Hospital
in Ústí nad Labem in the Czech
Republic, have unveiled groundbreaking findings from a study
showcasing the effectiveness of the Somavedic device in supporting
individuals with wet age-related macular degeneration (wet AMD), a
prevalent cause of severe vision impairment among older adults.
Breakthrough Study Reveals Somavedic
Device's Potential Impact on Wet AMD Patients
The study enrolled patients with newly diagnosed wet AMD
and active choroidal neovascularization (CNV), where anti-VEGF
therapy was indicated. Parameters including best corrected visual
acuity (BCVA), central macular thickness (CRT), macular volume
(TMV), and OCT angiography were monitored. Patients received a
functioning Somavedic device for home use, while the other group
was administered a non-functional placebo device.
After one month, results from 18 completed patient cases
revealed significant findings. Patients using the functional
Somavedic device (group A) experienced a mean improvement of +4.2
ETDRS letters in BCVA, accompanied by a reduction of -7.6 μm in CRT
and -0.232 mm3 in TMV. Conversely, patients in the control group
(group B) showed minimal changes in BCVA (+0 letters), with an
increase of +75 μm in CRT and +0.757 mm3 in TMV.
Dr. Martina Závorková, PhD the lead researcher of the study,
expressed enthusiasm regarding the results, stating, "Our findings
suggest that Somavedic may play an important role in slowing the
progression of age-related macular degeneration and offer a
promising, non-invasive adjunctive approach to managing wet AMD.
Further exploration is necessary to elucidate its mechanism of
action and long-term benefits."
"We are immensely encouraged by the positive outcomes of this
study, which underscore the potential of Somavedic to make a
meaningful impact on the lives of individuals affected by wet
age-related macular degeneration. This research reaffirms our
commitment to advancing innovative solutions that promote better
vision health and overall well-being," said Juraj Kocar, CEO of Somavedic Technologies.
The positive outcomes of this study pave the way for
larger-scale clinical trials to substantiate the efficacy of
Somavedic in wet AMD management. If validated, this innovative
technology has the potential to revolutionize treatment strategies
and significantly enhance the quality of life for individuals
affected by this debilitating eye condition.
About SOMAVEDIC:
Somavedic is an innovative,
always-on, rest and recovery frequency therapy device that
harmonizes any space and routine - from home to office. It works on
the principle of controlled release of natural energy from precious
minerals, stones, and metals, together with the supportive
frequency therapy technology, to provide a unique and one-of-a-kind
wellness-tech experience that renders a myriad of
scientifically-studied functional health benefits. Thanks to this
pioneering combination, the digital pollution-neutralizing effects
generated by Somavedic devices have therapeutic effects on our
cells, which manifest in improved sleep, energy levels, and
cellular regeneration. Somavedic combines these principles to bring
a calming, peaceful presence into our most sacred spaces - and does
so with effortless aesthetic beauty. Visit Somavedic.com or follow
the brand on Instagram at @somavedic.
Media Contact:
Aleksandra
Skalska
aleks@somavedic.com
P: +420 702 013 692
View original content to download
multimedia:https://www.prnewswire.com/news-releases/breakthrough-study-reveals-somavedic-devices-potential-impact-on-wet-amd-patients-302124621.html
SOURCE Somavedic Technologies Inc.